Back to Vontobel Holding Ltd. Vontobel Holding Ltd.

IOVA

9 quarters

Position history for Vontobel Holding Ltd.Vontobel Holding Ltd.'s holdings in Iovance Biotherapeutics, Inc.

No. Vontobel Holding exited its IOVA (Iovance Biotherapeutics) position in Q4 2025. Its Q3 2025 13F listed 12,067 shares worth $26,185. Vontobel Holding first reported IOVA in Q2 2023 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1M

Total Shares Change

-142,298

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$2.73
0
2025-Q3
New
12,067
-
$26,1850.0%$2.17
27
2025-Q1
Exited
0
-100.0%
$00.0%$3.33
0
2024-Q4
Increased
19,375
+2.3%
$143,3750.0%$7.40
23
2024-Q3
Increased
18,940
+32.5%
$177,8470.0%$9.39
29
2024-Q2
New
14,293
-
$114,6300.0%$8.02
30
2023-Q4
Exited
0
-100.0%
$00.0%$8.13
0
2023-Q3
Decreased
139,014
-2.3%
$632,5140.0%$4.55
0
2023-Q2
New
142,298
-
$1M0.0%$7.04
35

Other major holders of IOVA: ARK Investment Management LLC, Franklin Templeton Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used